MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis
Malignant pleural mesothelioma (MPM) is an incurable surface neoplasm with peculiar pathobiology. MPM proliferates by using the tyrosine-kinase-Ras pathway. Despite representing an attractive therapeutic target, there are no standard agent(s) specifically inhibiting Ras signaling adopted in clinical...
Main Authors: | Anand Singh, Nathanael Pruett, Roma Pahwa, Arushi P. Mahajan, David S. Schrump, Chuong D. Hoang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253121000949 |
Similar Items
-
Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade
by: Paola Indovina, et al.
Published: (2020-07-01) -
MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients
by: Ruby C.Y. Lin, et al.
Published: (2016-09-01) -
MicroRNA-31 Regulates Chemosensitivity in Malignant Pleural Mesothelioma
by: Moody, Hannah L., et al.
Published: (2020) -
Editorial: Epigenetic Modifications in Mesothelioma
by: Yuen Yee Cheng, et al.
Published: (2021-02-01) -
The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer
by: Roberta Roncarati, et al.
Published: (2019-09-01)